Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer with dismal survival rates. Resonant frequency therapy could become an invaluable treatment option in the future.
Studies conducted to date have demonstrated that exposure to ELF-EMF frequencies at which cancer cells resonate can reduce their growth; this phenomenon can be explained from an equilibrium thermodynamic standpoint.
Why it works
Researchers have discovered frequencies that can break cancer cells apart and strip away their protective layers, rendering them susceptible to chemotherapy or radiation treatments. Histotripsy uses these frequencies to disrupt tumor cell’s ability to hide antigens from being recognized by immune system; additionally its sound waves break apart tumor and may kill cancer cells that cannot be reached with these treatments.
Histotripsy employs ultrasound technology to target liver tumors with the goal of destroying them without harming healthy tissue. A probe placed on a patient’s abdomen moves across their skin over a tumor site while sound waves from a robotic arm deliver sound waves directly. Treatment doesn’t involve incisions, drugs, or radiation and is generally painless.
While histotripsy has proven successful for some patients, it remains a relatively new technology with potential side effects including chemotherapy brain (which impacts concentration and focus), nausea and vomiting, nerve issues, changes in libido or fertility issues as well as potential risks such as septic shock or infections in the liver that result in bleeding in that organ.
Histotripsy researchers have discovered that tumor tissues differ from normal tissue in their relative elasticity, affecting the resonant frequency of an acoustic sensor and thus providing information for scanning various tumors on athymic nude mice flanks. Their analysis demonstrated how using the LC sensor could distinguish alive from dead tumor tissue by its resonant frequency.
Holland conducted experiments to assess the effect of various frequencies on pancreatic cancer cells and found they were most vulnerable between 100,000 and 300,000 Hz. His team then turned their focus onto leukemia cancer cells, effectively shattering them during repeated experiments by up to 65% or killing or slowing their growth rates altogether.
Scientists hope resonant frequencies can be used to destroy tumors in the human body and prevent their spread across different areas of the body, particularly with metastatic liver cancer, which spreads quickly across parts of its target organ. Resonant frequencies could prove particularly helpful against metastatic liver cancer as this kind of cancer tends to move from region to region within an individual’s body.
How it works
People of us all understand that when our voices match up with their natural resonant frequency, our voice can shatter glass like never before. But Carrie, a mother of two from Utah underwent resonance frequency therapy for liver cancer treatment between 2022-2021 – it truly worked wonders!
Her doctors administered anesthesia before moving an ultrasound transducer over her abdomen to locate its exact location in her liver organ. Once they had located it, a larger ultrasound probe was then used to deliver sound waves at high-frequency directly towards cancerous lesions causing them to vibrate and ultimately dissolve themselves through mechanical shockwaves that penetrated its cells and caused its destruction.
After performing the process on various parts of their bodies, the team repeated it to see if other tissues responded similarly to sound wave treatment as liver tissue. They discovered that dead flank tumor tissue resonated at higher frequency compared to living benign liver tissues and this led them to conclude that soundwave therapy can effectively target dead tumors as well.
Resonant frequencies between healthy and tumor cells vary due to a change in energy transformation within their respective cells, with cancer cells having an imbalanced conversion of energy from nutrients into work for survival and proliferation. Exposure to ELF-EMF exposure changes this balance and inhibits cancer cell proliferation by changing metabolic shift.
Histotripsy — sound waves used to disrupt tumor structures and kill them — also stimulates your immune system’s defenses against cancer – an advantage over treatments using harsh chemicals which may cause serious side effects.
Histotripsy may be an effective tool in fighting liver cancer and other types of malignancies, by exposing tumor antigens that cancer uses to hide itself, so the immune system can identify and destroy them. Histotripsy was proven successful against over 80% of rats studied after treatment using histotripsy with no recurrence or metastases observed afterwards.
Side effects
Resonant frequency therapy not only can kill cancer cells but can also stimulate the body’s natural immune response system to attack foreign invaders. Last spring, research published in Frontiers in Immunology demonstrated that sound waves used for histotripsy could remove 50-75% of liver tumor mass while simultaneously inducing an immune response which prevented further tumor growth in over 80% of rats. Tumor antigens were revealed to be key elements in fighting cancer cells, being proteins unique to cancer cells that lie hidden behind their cell walls and released upon tumor cell death to alert immune system that there are cancerous cells present. Resonant frequency therapy could potentially aid the body’s defense system by targeting cancer cell membrane channels and deforming them to activate immune responses more effectively against tumor cells.
AutEMdev and P1 devices were found to successfully treat patients with advanced HCC (hepatocellular carcinoma). A 30-minute discovery phase with real-time multiparameter haemodynamic monitoring revealed personalized frequencies causing subtle but reproducible changes in mitochondrial ATP production in each patient, leading to reduced tumour size, radiological progression (documented via diffusion/artery phase magnetic resonance imaging), longer survival compared to historical controls.
Scientists believe these results demonstrate a fundamental interaction between resonant frequencies selected for exposure and the subcellular structures of cancer cells, which in turn inhibit their proliferation through modulating mitochondrial metabolism and calcium fluxes. This particular effect lays the groundwork for personalized cancer therapy in which tumor’s characteristic resonant frequency is used to target its molecular features and reduce proliferative potential.
“This technique provides an exciting proof-of-concept for an innovative method to target the source of disease,” Holland notes, who collaborates on his project with Caltech undergraduate Ankita Roychoudhury and Leyre Troyas Martinez, an MIT graduate student supported by a Caltech Summer Undergraduate Research Fellowship. Furthermore, Holland points out that his technique may eventually be integrated with traditional forms of medical treatment to better treat tumors.
Conclusions
Similar to how Earth’s magnetic field affects geomagnetic fluctuations, Schumann resonance and cell pulsations, an electromagnetic wave in the ELF range may also have an amplifying effect on microtubule ion flows. An entire 20 nm microtubule would resonate at 27 MHz, which is close to both its fundamental oscillation frequency in electrophysiological studies and envelope wave frequency of LEAM RF EMF devices (as shown below). We believe this resonant coupling between intracellular vibrations of charged macromolecules and ion flow coupled with an RF EMF carrier wave may change cell morphology and subcellular trafficking of mitochondria, potentially altering metabolism of cancer cells to have long-term anticancer effects.
Resonant coupling of intracellular vibrations to LEAM RF EMF envelope waves has also shown to inhibit cancer cell growth both in vitro and mouse xenograft models, with minorities of patients experiencing tumor regressions compared to historical controls with minimal side effects (other than mild transient somnolence). Uncontrolled prospective clinical studies using AutEMdev device on patients with HCC showed minimal side effects (other than mild transient somnolence).
Resonant frequency therapy differs from ultrasound-based therapies by being non-invasive and its thermal effects being limited by surrounding healthy tissues. Resonant frequency therapy‘s potential to produce long-lasting metabolic changes could offer a viable solution and provide an alternative approach to more invasive cancer treatments, such as surgery, radiotherapy or chemotherapy. At present, only five clinical studies have used AutEMdev device on patients with cancer to date and have produced promising results that need to be verified through randomized controlled trials. Still, LEAM RF EMF devices combined with patient-specific frequencies that select envelope waves make this therapy an attractive candidate for personalized cancer treatments and research into this field is ongoing.
